β-Blockers Restore Calcium Release Channel Function and Improve Cardiac Muscle Performance in Human Heart Failure
- 20 May 2003
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Cell Metabolism
- Vol. 107 (19), 2459-2466
- https://doi.org/10.1161/01.cir.0000068316.53218.49
Abstract
Background— Chronic β-adrenergic receptor (β-AR) blockade improves cardiac contractility and prolongs survival in patients with heart failure; however, the mechanisms underlying these favorable responses are poorly understood. Stress-induced activation of the sympathetic nervous system results in protein kinase A (PKA)-mediated phosphorylation of the calcium (Ca2+) release channel/cardiac ryanodine receptor (RyR2), required for cardiac excitation-contraction (EC) coupling, activating the RyR2 channel, and increasing cardiac contractility. The hyperadrenergic state of heart failure results in leaky RyR2 channels attributable to PKA hyperphosphorylation and depletion of the stabilizing FK506 binding protein, FKBP12.6. We tested the hypothesis that improved cardiac muscle function attributable to β-AR blockade is associated with restoration of normal RyR2 channel function in patients with heart failure. Methods and Results— We assessed the effects of β-AR blockade on left ventricular volume using isolated perfused hearts and β-agonist responsiveness using muscle strips from patients undergoing transplantation. Twenty-four human hearts were examined, 10 from patients with heart failure treated with β-AR blockers (carvedilol, metoprolol, or atenolol), 9 from patients with heart failure without β-AR blocker treatment, and 5 normal hearts. RyR2 PKA phosphorylation was determined by back-phosphorylation, FKBP12.6 in the RyR2 macromolecular complex was determined by coimmunoprecipitation, and channel function was assayed using planar lipid bilayers. β-AR blockers reduced left ventricular volume (reverse remodeling) and restored β-agonist response in cardiac muscle from patients with heart failure. Improved cardiac muscle function was associated with restoration of normal FKBP12.6 levels in the RyR2 macromolecular complex and RyR2 channel function. Conclusions— Improved cardiac muscle function during β-AR blockade is associated with improved cardiac Ca2+ release channel function in patients with heart failure.Keywords
This publication has 33 references indexed in Scilit:
- Propranolol Prevents the Development of Heart Failure by Restoring FKBP12.6-Mediated Stabilization of Ryanodine ReceptorCirculation, 2002
- Phosphorylation-Dependent Regulation of Ryanodine ReceptorsThe Journal of cell biology, 2001
- Ryanodine Receptors/Calcium Release channels in Heart Failure and Sudden Cardiac DeathJournal of Molecular and Cellular Cardiology, 2001
- PKA Phosphorylation Dissociates FKBP12.6 from the Calcium Release Channel (Ryanodine Receptor)Cell, 2000
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Coupled Gating Between Individual Skeletal Muscle Ca 2+ Release Channels (Ryanodine Receptors)Science, 1998
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Phosphorylation Modulates the Function of the Calcium Release Channel of Sarcoplasmic Reticulum from Cardiac MuscleJournal of Biological Chemistry, 1995
- The Ryanodine Receptor from Canine Heart Sarcoplasmic Reticulum Is Associated with a Novel FK-506 Binding ProteinBiochemical and Biophysical Research Communications, 1994
- Regulation of Calcium Release Is Gated by Calcium Current, Not Gating Charge, in Cardiac MyocytesScience, 1989